• Medication Therapy Management (MTM)

    Chalice Pharmaceuticals offers MTM programs that encompass both Comprehensive Medication Reviews (CMRs) and Targeted Medication Reviews (TMRs). Our Medicare MTM programs are designed to comply with CMS requirements for Medicare Part D plans, including the identification of Drug Therapy Problems (DPT), when present. Our solutions deliver the Personal Medication List and Medication Action Plan in the CMS standardized format, and ensure ongoing review of Drug Therapy Problems through quarterly performance of TMRs.
    Chalice’s standard MTM programs address all the Part D medication-related Patient Safety measures as well as many elements that can improve Part C measures, display measures, or HEDIS scores. Chalice’s MTM CMR is consistent with the Core Elements of the MTM model developed by APhA and NACDS.

    Targeted Quality Intervention

    Chalice offers a Targeted Quality Intervention solution for patients who do not qualify for MTM service but who appear to have drug therapy problems based on prescription claims analysis. For such patients, pharmacist intervention could resolve drug therapy problems, improve quality of care and clinical outcomes, and/or reduce health care costs.

    Medication Therapy Management (MTM)

    The Targeted Quality Intervention solution may be combined with an MTM program to address a wide range of patients with the right service for each. Above is an example of a Medicaid product solution which leverages a combination of Medication Therapy Management (MTMP) and Targeted Quality Interventions.
    Chalice can analyze prescription drug claims to identify potential drug therapy problems to optimize safety and quality, in support of the following Medicaid Plan HEDIS quality measures:

    • Medication Management for People with Asthma
    • Asthma Medication Ratio
    • Statin Therapy and Diabetes
    • Antidepressant Medication Management
    • Antipsochotic Medication in Schizophrenia
    • Diabetes Care (blood sugar / A1c controlled)

    Star Ratings

    Chalice supports successful pharmacist intervention to help improve patient safety, encourage quality care, and raise patient satisfaction – positively influencing CMS Five-Star Ratings.
    Chalice’s Star Ratings solutions target Medicare Part D drug safety measures as well as many Part C measures. Chalice or clients identify health plan members most in need of quality of care improvements impacting specific Star Ratings measures and the Chalice’s network of pharmacies engages these members to educate, influence, and promote behavioral changes needed to positively influence measures and optimize health outcomes.

    Disease Specific Medication Management

    Chalice’s Disease Management solutions improve patients’ knowledge of their conditions including diabetes, asthma, and cardiovascular disease. This increases patients’ adherence to their medication regimens, and improves patients’ ability to self-manage and monitor their chronic conditions. Strengthening control of chronic conditions can significantly impact long-term wellness and deliver significant cost savings.

    30 to 90-Day Switch

    The 30 to 90-Day Switch solution is designed to enhance medication adherence by helping patients switch a 30-day supply of their medications to a 90-day supply.
    For additional information about any of our solutions, please contact us at chalicepharm@gmail.com

  • Chalice Pharmaceuticals has developed customized clinical rules to address quality measures such as Star Ratings, HEDIS, and other evidence-based standards of care.

    Star Ratings

    Medicare Part D plans (PDP) and Medicare Advantage plans with prescription benefit (MA-PD) are rated on multiple performance measures. Chalice MTM Programs and Star Ratings solutions address the drug safety measures that can influence and improve about 40% of total Part D summary rating.

    Our solutions address:

    • High Risk Medications
    • Medication Adherence for Diabetes Medications
    • Medication Adherence for Hypertension (RAS antagonists)
    • Medication Adherence for Cholesterol (Statins)
    • Medication Management for People with Asthma
    • Statin Therapy and Diabetes
    • Antidepressant Management
    • Anti-psychotic Medication in Schizophrenia
  • Chalice Pharmaceuticals ensures that all patient information are kept confidential and remains compliant with HIPAA